Kantonsspital Luzern

Lucerne, Canton of Lucerne 6000

0 studies enrolling now · 4 studies all time

What they study most

Any Solid Tumor, Breast Cancer, Colon Cancer, Lymphoma, Mantle-Cell, Medullary Thyroid Cancer, Migraine, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Other Solid Tumors With Evidence of Activating RET Alteration, Pancreatic Cancer, Papillary Thyroid Cancer

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
• Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation — APPROVED_FOR_MARKETING
• A Study of Lasmiditan (LY573144) Over Four Migraine Attacks — Completed